Our group and others have reported on the prognostic significance of multiallelic TP53 aberrations; however, results from other studies have been mixed, and thus the significance of detecting somatic mutations in addition to CNAs in CLL has not definitively been defined [32,33,34]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.